Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

9.4%

16 terminated/withdrawn out of 171 trials

Success Rate

84.8%

-1.8% vs industry average

Late-Stage Pipeline

9%

15 trials in Phase 3/4

Results Transparency

1%

1 of 89 completed trials have results

Key Signals

32 recruiting1 with results16 terminated

Enrollment Performance

Analytics

N/A
71(55.9%)
Phase 2
29(22.8%)
Phase 3
13(10.2%)
Phase 1
11(8.7%)
Phase 4
2(1.6%)
Early Phase 1
1(0.8%)
127Total
N/A(71)
Phase 2(29)
Phase 3(13)
Phase 1(11)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (171)

Showing 20 of 171 trials
NCT03246841Not ApplicableActive Not Recruiting

Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes.

Role: collaborator

NCT05282901Phase 2Completed

Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME)

Role: lead

NCT06225505Not ApplicableRecruiting

Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)

Role: lead

NCT07491380Not ApplicableRecruiting

Validation of Capillary Microsampling for Therapeutic Drug Monitoring of CDK4/6 Inhibitors in Breast Cancer Patients (TDHOME)

Role: lead

NCT05634395Not ApplicableCompleted

Digital Phenotyping in Women Over 70 Years of Age Treated for Breast Cancer With Any Type of Treatment

Role: lead

NCT04733027Early Phase 1Completed

First-in-human Phase I to Evaluate PEP-010 as Single Agent and in Combination With Paclitaxel or With Gemcitabine (CleverPeptide)

Role: lead

NCT05558644Not ApplicableRecruiting

Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs)

Role: lead

NCT05441163Not ApplicableRecruiting

ProActIF-01 Trial: Feasibility Study of an Individualized Program of Nutrition and Adapted Physical Activity in Frail Patients With Advanced Digestive Cancers

Role: lead

NCT05931302Not ApplicableActive Not Recruiting

Initial Staging of Lobular Breast Carcinoma: Head to Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT

Role: collaborator

NCT03739775Not ApplicableCompleted

Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses (CIRCA-HPV)

Role: lead

NCT07357948Not ApplicableNot Yet Recruiting

Omission of Surgery for Triple-negative Breast Cancer in Complete Response After Neoadjuvant Chemo-immunotherapy

Role: lead

NCT06439901Not ApplicableRecruiting

Optimizing Bronchopulmonary Cancer Screening

Role: lead

NCT01689584Not ApplicableRecruiting

COsegregation of VARiants in Panel of Genes

Role: lead

NCT07602387Not ApplicableRecruiting

Chemotherapy Induced Peripheral Neuropathy by Taxanes and Capsaicin 8%.

Role: collaborator

NCT07571564Recruiting

Adherence to Enteral Nutrition

Role: lead

NCT05293197Phase 1Recruiting

Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients

Role: collaborator

NCT05354765Not ApplicableRecruiting

Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer Patients : ALCYTA

Role: lead

NCT05475366Not ApplicableRecruiting

Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures

Role: lead

NCT06581809Not ApplicableTerminated

Comparative Evaluation of Care Strategies on Dressing Change-induced Bleeding in Patients With Bleeding Malignant Wounds (Tumoss)

Role: lead

NCT04731610Not ApplicableRecruiting

Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma (RADIO-RYTHMIC-01)

Role: lead